II
AGIO icon

Inspire Investing’s Agios Pharmaceuticals AGIO Stock Holding History

Inspire Investing’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$678K Buy
18,269
+3,529
+24% +$107K 0.03% 774
2026
Q1 		$499K Sell
14,740
-2,375
-14% -$67.3K 0.03% 841
2025
Q4 		$466K Buy
17,115
+5,720
+50% +$201K 0.04% 653
2025
Q3 		$457K Sell
11,395
-333
-3% -$12.5K 0.04% 421
2025
Q2 		$390K Sell
11,728
-40
-0.3% -$1.21K 0.04% 520
2025
Q1 		$345K Sell
11,768
-616
-5% -$20.4K 0.04% 452
2024
Q4 		$407K Buy
12,384
+3,156
+34% +$148K 0.05% 367
2024
Q3 		$410K Buy
9,228
+1,113
+14% +$50.5K 0.04% 706
2024
Q2 		$350K Sell
8,115
-4,087
-33% -$148K 0.04% 666
2024
Q1 		$357K Sell
12,202
-5,011
-29% -$134K 0.04% 712
2023
Q4 		$383K Buy
17,213
+4,869
+39% +$109K 0.04% 607
2023
Q3 		$306K Buy
12,344
+1,327
+12% +$35.1K 0.04% 711
2023
Q2 		$312K Sell
11,017
-826
-7% -$20.6K 0.04% 752
2023
Q1 		$272K Buy
11,843
+3,366
+40% +$89.4K 0.03% 689
2022
Q4 		$238K Buy
8,477
+1,199
+16% +$33.8K 0.03% 374
2022
Q3 		$206K Buy
+7,278
New +$195K 0.03% 585

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Inspire Investing's AGIO Position: Q2 2026 in Review

Inspire Investing increased its Agios Pharmaceuticals (AGIO) stake by 24% in Q2 2026, buying an estimated $107K and bringing the position to 18,269 shares worth $678K. The position accounts for 0.03% of the portfolio, ranked #774.

Inspire Investing first reported a position in AGIO in Q3 2022 and has held it in 16 quarters since. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Inspire Investing held 18,269 shares of Agios Pharmaceuticals worth $678K as of Q2 2026.
  • Inspire Investing bought 3,529 Agios Pharmaceuticals shares in Q2 2026, an estimated $107K.
  • Agios Pharmaceuticals made up 0.03% of Inspire Investing's portfolio in Q2 2026, its #774 holding.
  • Inspire Investing first reported a position in Agios Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Inspire Investing's 13F filing for Q2 2026, filed 12 Aug 2026.